<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 20 Apr 2026 00:38:34 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>UBS Downgrades Hang Lung Prop (101:HK) (HLPPY) to Neutral</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</link>
   <description>&lt;p&gt;UBS analyst Mark Leung downgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Buy to Neutral with a price target of HK$9.60.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We downgrade Hang Lung Properties (HLP) to Neutral as our PT has been reached and we don’t expect any near term re-rating catalysts, despite the stock trading at a low P/B of 0.36x. On the one hand, we see limited scope for DPS hikes in the near term, as HLP's operating cash flow is only largely able to cover its annual dividend payment. It will also take time for Hangzhou Westlake 66 to fully ramp up, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</guid>
   <pubDate>Mon, 20 Apr 2026 00:38:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>UBS Downgrades Hang Lung Prop (101:HK) (HLPPY) to Neutral</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</link>
   <description>&lt;p&gt;UBS analyst Mark Leung downgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Buy to Neutral with a price target of HK$9.60.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We downgrade Hang Lung Properties (HLP) to Neutral as our PT has been reached and we don’t expect any near term re-rating catalysts, despite the stock trading at a low P/B of 0.36x. On the one hand, we see limited scope for DPS hikes in the near term, as HLP's operating cash flow is only largely able to cover its annual dividend payment. It will also take time for Hangzhou Westlake 66 to fully ramp up, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</guid>
   <pubDate>Mon, 20 Apr 2026 00:38:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>UBS Downgrades Hang Lung Prop (101:HK) (HLPPY) to Neutral</title>
   <link>http://www.streetinsider.com/Downgrades/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</link>
   <description>&lt;p&gt;UBS analyst Mark Leung downgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Buy to Neutral with a price target of HK$9.60.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We downgrade Hang Lung Properties (HLP) to Neutral as our PT has been reached and we don’t expect any near term re-rating catalysts, despite the stock trading at a low P/B of 0.36x. On the one hand, we see limited scope for DPS hikes in the near term, as HLP's operating cash flow is only largely able to cover its annual dividend payment. It will also take time for Hangzhou Westlake 66 to fully ramp up, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Downgrades/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</guid>
   <pubDate>Mon, 20 Apr 2026 00:38:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>UBS Downgrades Hang Lung Prop (101:HK) (HLPPY) to Neutral</title>
   <link>http://www.streetinsider.com/Downgrades/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</link>
   <description>&lt;p&gt;UBS analyst Mark Leung downgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Buy to Neutral with a price target of HK$9.60.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We downgrade Hang Lung Properties (HLP) to Neutral as our PT has been reached and we don’t expect any near term re-rating catalysts, despite the stock trading at a low P/B of 0.36x. On the one hand, we see limited scope for DPS hikes in the near term, as HLP's operating cash flow is only largely able to cover its annual dividend payment. It will also take time for Hangzhou Westlake 66 to fully ramp up, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Downgrades/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</guid>
   <pubDate>Mon, 20 Apr 2026 00:38:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>UBS Downgrades Hang Lung Prop (101:HK) (HLPPY) to Neutral</title>
   <link>http://www.streetinsider.com/Analyst+Comments/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</link>
   <description>&lt;p&gt;UBS analyst Mark Leung downgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Buy to Neutral with a price target of HK$9.60.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We downgrade Hang Lung Properties (HLP) to Neutral as our PT has been reached and we don’t expect any near term re-rating catalysts, despite the stock trading at a low P/B of 0.36x. On the one hand, we see limited scope for DPS hikes in the near term, as HLP's operating cash flow is only largely able to cover its annual dividend payment. It will also take time for Hangzhou Westlake 66 to fully ramp up, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</guid>
   <pubDate>Mon, 20 Apr 2026 00:38:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>UBS Downgrades Hang Lung Prop (101:HK) (HLPPY) to Neutral</title>
   <link>http://www.streetinsider.com/Analyst+Comments/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</link>
   <description>&lt;p&gt;UBS analyst Mark Leung downgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Buy to Neutral with a price target of HK$9.60.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We downgrade Hang Lung Properties (HLP) to Neutral as our PT has been reached and we don’t expect any near term re-rating catalysts, despite the stock trading at a low P/B of 0.36x. On the one hand, we see limited scope for DPS hikes in the near term, as HLP's operating cash flow is only largely able to cover its annual dividend payment. It will also take time for Hangzhou Westlake 66 to fully ramp up, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/UBS+Downgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Neutral/26332615.html</guid>
   <pubDate>Mon, 20 Apr 2026 00:38:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$11.20 at Citi</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</link>
   <description>Citi analyst Cindy Li raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$11.20  (from HK$10.10) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</guid>
   <pubDate>Wed, 04 Feb 2026 04:05:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$11.20 at Citi</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</link>
   <description>Citi analyst Cindy Li raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$11.20  (from HK$10.10) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</guid>
   <pubDate>Wed, 04 Feb 2026 04:05:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$11.20 at Citi</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</link>
   <description>Citi analyst Cindy Li raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$11.20  (from HK$10.10) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</guid>
   <pubDate>Wed, 04 Feb 2026 04:05:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$11.20 at Citi</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</link>
   <description>Citi analyst Cindy Li raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$11.20  (from HK$10.10) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2411.20+at+Citi/25941866.html</guid>
   <pubDate>Wed, 04 Feb 2026 04:05:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$12 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</link>
   <description>&lt;p&gt;JPMorgan analyst Karl Chan raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$12.00 (from HK$11.50) while maintaining a Overweight rating.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We believe the FY25 results confirm a recovery in HLP’s Mainland China tenant sales, with (1) +18% Y/Y in 4Q25 (reaching a record-high), up from +10% Y/Y in 3Q25; (2) management expecting MSD% growth in FY26E (with good momentum so far in January 2026). At (1) 66% NAV discount; (2) 0.3x P/B; (3) 5.5% yield (with upside risk starting in FY27E), we think HLP remains under- appreciated: (1) HLP is a “China luxury retail</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</guid>
   <pubDate>Mon, 02 Feb 2026 02:26:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$12 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</link>
   <description>&lt;p&gt;JPMorgan analyst Karl Chan raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$12.00 (from HK$11.50) while maintaining a Overweight rating.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We believe the FY25 results confirm a recovery in HLP’s Mainland China tenant sales, with (1) +18% Y/Y in 4Q25 (reaching a record-high), up from +10% Y/Y in 3Q25; (2) management expecting MSD% growth in FY26E (with good momentum so far in January 2026). At (1) 66% NAV discount; (2) 0.3x P/B; (3) 5.5% yield (with upside risk starting in FY27E), we think HLP remains under- appreciated: (1) HLP is a “China luxury retail</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</guid>
   <pubDate>Mon, 02 Feb 2026 02:26:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$12 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</link>
   <description>&lt;p&gt;JPMorgan analyst Karl Chan raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$12.00 (from HK$11.50) while maintaining a Overweight rating.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We believe the FY25 results confirm a recovery in HLP’s Mainland China tenant sales, with (1) +18% Y/Y in 4Q25 (reaching a record-high), up from +10% Y/Y in 3Q25; (2) management expecting MSD% growth in FY26E (with good momentum so far in January 2026). At (1) 66% NAV discount; (2) 0.3x P/B; (3) 5.5% yield (with upside risk starting in FY27E), we think HLP remains under- appreciated: (1) HLP is a “China luxury retail</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</guid>
   <pubDate>Mon, 02 Feb 2026 02:26:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$12 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</link>
   <description>&lt;p&gt;JPMorgan analyst Karl Chan raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$12.00 (from HK$11.50) while maintaining a Overweight rating.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We believe the FY25 results confirm a recovery in HLP’s Mainland China tenant sales, with (1) +18% Y/Y in 4Q25 (reaching a record-high), up from +10% Y/Y in 3Q25; (2) management expecting MSD% growth in FY26E (with good momentum so far in January 2026). At (1) 66% NAV discount; (2) 0.3x P/B; (3) 5.5% yield (with upside risk starting in FY27E), we think HLP remains under- appreciated: (1) HLP is a “China luxury retail</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</guid>
   <pubDate>Mon, 02 Feb 2026 02:26:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$12 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</link>
   <description>&lt;p&gt;JPMorgan analyst Karl Chan raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$12.00 (from HK$11.50) while maintaining a Overweight rating.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We believe the FY25 results confirm a recovery in HLP’s Mainland China tenant sales, with (1) +18% Y/Y in 4Q25 (reaching a record-high), up from +10% Y/Y in 3Q25; (2) management expecting MSD% growth in FY26E (with good momentum so far in January 2026). At (1) 66% NAV discount; (2) 0.3x P/B; (3) 5.5% yield (with upside risk starting in FY27E), we think HLP remains under- appreciated: (1) HLP is a “China luxury retail</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</guid>
   <pubDate>Mon, 02 Feb 2026 02:26:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$12 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</link>
   <description>&lt;p&gt;JPMorgan analyst Karl Chan raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$12.00 (from HK$11.50) while maintaining a Overweight rating.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We believe the FY25 results confirm a recovery in HLP’s Mainland China tenant sales, with (1) +18% Y/Y in 4Q25 (reaching a record-high), up from +10% Y/Y in 3Q25; (2) management expecting MSD% growth in FY26E (with good momentum so far in January 2026). At (1) 66% NAV discount; (2) 0.3x P/B; (3) 5.5% yield (with upside risk starting in FY27E), we think HLP remains under- appreciated: (1) HLP is a “China luxury retail</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2412+at+JPMorgan/25925646.html</guid>
   <pubDate>Mon, 02 Feb 2026 02:26:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$10 at BofA Securities</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</link>
   <description>BofA Securities analyst Karl Choi raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$10.00  (from HK$9.60) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</guid>
   <pubDate>Mon, 29 Sep 2025 04:59:35 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$10 at BofA Securities</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</link>
   <description>BofA Securities analyst Karl Choi raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$10.00  (from HK$9.60) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</guid>
   <pubDate>Mon, 29 Sep 2025 04:59:35 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$10 at BofA Securities</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</link>
   <description>BofA Securities analyst Karl Choi raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$10.00  (from HK$9.60) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</guid>
   <pubDate>Mon, 29 Sep 2025 04:59:35 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Hang Lung Prop (101:HK) (HLPPY) PT Raised to HK$10 at BofA Securities</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</link>
   <description>BofA Securities analyst Karl Choi raised the price target on Hang Lung Prop (101:HK) (OTC: HLPPY) to HK$10.00  (from HK$9.60) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+PT+Raised+to+HK%2410+at+BofA+Securities/25387015.html</guid>
   <pubDate>Mon, 29 Sep 2025 04:59:35 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Morgan Stanley Upgrades Hang Lung Prop (101:HK) (HLPPY) to Overweight</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</link>
   <description>&lt;p&gt;Morgan Stanley analyst Praveen Choudhary upgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Equalweight to Overweight with a price target of HK$9.00 (from HK$6.50).&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;In the near term, we see improving luxury sales in Shanghai for quality malls (especially the HK developers) with the help of local brands, inbound travelers, and ease of tax-free shopping/reimbursement.&lt;br /&gt;Over the long run, we expect China's inbound travel retail sales to quadruple in 10 years. Westlake 66, the new Hangzhou project, could be the new growth driver, with minimal capex outlay for the expansion (adding 452k sqf GFA). Optionality from the potential</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</guid>
   <pubDate>Fri, 05 Sep 2025 02:31:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Morgan Stanley Upgrades Hang Lung Prop (101:HK) (HLPPY) to Overweight</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</link>
   <description>&lt;p&gt;Morgan Stanley analyst Praveen Choudhary upgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Equalweight to Overweight with a price target of HK$9.00 (from HK$6.50).&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;In the near term, we see improving luxury sales in Shanghai for quality malls (especially the HK developers) with the help of local brands, inbound travelers, and ease of tax-free shopping/reimbursement.&lt;br /&gt;Over the long run, we expect China's inbound travel retail sales to quadruple in 10 years. Westlake 66, the new Hangzhou project, could be the new growth driver, with minimal capex outlay for the expansion (adding 452k sqf GFA). Optionality from the potential</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</guid>
   <pubDate>Fri, 05 Sep 2025 02:31:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Morgan Stanley Upgrades Hang Lung Prop (101:HK) (HLPPY) to Overweight</title>
   <link>http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</link>
   <description>&lt;p&gt;Morgan Stanley analyst Praveen Choudhary upgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Equalweight to Overweight with a price target of HK$9.00 (from HK$6.50).&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;In the near term, we see improving luxury sales in Shanghai for quality malls (especially the HK developers) with the help of local brands, inbound travelers, and ease of tax-free shopping/reimbursement.&lt;br /&gt;Over the long run, we expect China's inbound travel retail sales to quadruple in 10 years. Westlake 66, the new Hangzhou project, could be the new growth driver, with minimal capex outlay for the expansion (adding 452k sqf GFA). Optionality from the potential</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</guid>
   <pubDate>Fri, 05 Sep 2025 02:31:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Morgan Stanley Upgrades Hang Lung Prop (101:HK) (HLPPY) to Overweight</title>
   <link>http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</link>
   <description>&lt;p&gt;Morgan Stanley analyst Praveen Choudhary upgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Equalweight to Overweight with a price target of HK$9.00 (from HK$6.50).&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;In the near term, we see improving luxury sales in Shanghai for quality malls (especially the HK developers) with the help of local brands, inbound travelers, and ease of tax-free shopping/reimbursement.&lt;br /&gt;Over the long run, we expect China's inbound travel retail sales to quadruple in 10 years. Westlake 66, the new Hangzhou project, could be the new growth driver, with minimal capex outlay for the expansion (adding 452k sqf GFA). Optionality from the potential</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</guid>
   <pubDate>Fri, 05 Sep 2025 02:31:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
  <item>
   <title>Morgan Stanley Upgrades Hang Lung Prop (101:HK) (HLPPY) to Overweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</link>
   <description>&lt;p&gt;Morgan Stanley analyst Praveen Choudhary upgraded Hang Lung Prop (101:HK) (OTC: HLPPY) from Equalweight to Overweight with a price target of HK$9.00 (from HK$6.50).&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;In the near term, we see improving luxury sales in Shanghai for quality malls (especially the HK developers) with the help of local brands, inbound travelers, and ease of tax-free shopping/reimbursement.&lt;br /&gt;Over the long run, we expect China's inbound travel retail sales to quadruple in 10 years. Westlake 66, the new Hangzhou project, could be the new growth driver, with minimal capex outlay for the expansion (adding 452k sqf GFA). Optionality from the potential</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Upgrades+Hang+Lung+Prop+%28101%3AHK%29+%28HLPPY%29+to+Overweight/25300218.html</guid>
   <pubDate>Fri, 05 Sep 2025 02:31:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HLPPY</category>
   	  </item>
 </channel>
</rss>
